APO Research
Talk to an analyst

APO RESEARCH · REPORT

Contact-lens Induced Infection

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Contact-lens Induced Infection Industry Growth and Trends Forecast to 2032

28 December 2025113 pages

Choose your research edition.

Industry ResearchContact-lens Induced Infection Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Contact-lens Induced Infection Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Contact-lens Induced Infection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Contact-lens Induced Infection Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Contact-lens Induced Infection Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

According to APO Research, the global Contact-lens Induced Infection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Contact-lens Induced Infection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Contact-lens Induced Infection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Contact-lens Induced Infection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Contact-lens Induced Infection market include Teva Pharmaceutical, Merck & Co., Pfizer, Alcon, AbbVie, Shionogi, Santen Pharmaceutical, Roche Holding and Otsuka Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Contact-lens Induced Infection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Contact-lens Induced Infection market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Contact-lens Induced Infection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Contact-lens Induced Infection.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Contact-lens Induced Infection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Contact-lens Induced Infection Market by Company

Teva Pharmaceutical

Merck & Co.

Pfizer

Alcon

AbbVie

Shionogi

Santen Pharmaceutical

Roche Holding

Otsuka Pharmaceutical

Novartis International

Kowa Company

Hikma Pharmaceuticals

Dr. Reddy’s Laboratories

Bausch + Lomb

AstraZeneca

Contact-lens Induced Infection Segment by Type

Corticosteroids

Anti-inflammatory Drugs

Antibiotics

NSAIDs

Other

Contact-lens Induced Infection Segment by Application

Retail Pharmacy

Ophthalmology Clinics

Hospitals

Other

Contact-lens Induced Infection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Contact-lens Induced Infection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Contact-lens Induced Infection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Contact-lens Induced Infection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Contact-lens Induced Infection companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Contact-lens Induced Infection Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Contact-lens Induced Infection Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Contact-lens Induced Infection Market Share by Region (2021-2026) Table 4. Global Contact-lens Induced Infection Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Contact-lens Induced Infection Market Share by Region (2027-2032) Table 6. Global Contact-lens Induced Infection Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Contact-lens Induced Infection Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Contact-lens Induced Infection Market Size Share by Type (2021-2026) Table 9. Global Contact-lens Induced Infection Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Contact-lens Induced Infection Market Size Share Forecasted by Type (2027-2032) Table 11. North America Contact-lens Induced Infection Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Contact-lens Induced Infection Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Contact-lens Induced Infection Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Contact-lens Induced Infection Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Contact-lens Induced Infection Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Contact-lens Induced Infection Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Contact-lens Induced Infection Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Contact-lens Induced Infection Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Contact-lens Induced Infection Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Contact-lens Induced Infection Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Contact-lens Induced Infection Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Contact-lens Induced Infection Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Contact-lens Induced Infection Market Size Share by Application (2021-2026) Table 24. Global Contact-lens Induced Infection Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Contact-lens Induced Infection Market Size Share Forecasted by Application (2027-2032) Table 26. North America Contact-lens Induced Infection Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Contact-lens Induced Infection Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Contact-lens Induced Infection Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Contact-lens Induced Infection Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Contact-lens Induced Infection Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Contact-lens Induced Infection Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Contact-lens Induced Infection Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Contact-lens Induced Infection Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Contact-lens Induced Infection Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Contact-lens Induced Infection Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Contact-lens Induced Infection Industry Trends Table 37. Contact-lens Induced Infection Industry Drivers Table 38. Contact-lens Induced Infection Industry Opportunities and Challenges Table 39. Contact-lens Induced Infection Industry Restraints Table 40. Global Contact-lens Induced Infection Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Contact-lens Induced Infection Revenue Market Share by Company (2021-2026) Table 42. Global Contact-lens Induced Infection Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Contact-lens Induced Infection Key Company Headquarters & Area Served Table 44. Global Contact-lens Induced Infection Company, Product Type & Application Table 45. Global Contact-lens Induced Infection Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Contact-lens Induced Infection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Teva Pharmaceutical Company Information Table 49. Teva Pharmaceutical Business Overview Table 50. Teva Pharmaceutical Contact-lens Induced Infection Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Teva Pharmaceutical Contact-lens Induced Infection Product Portfolio Table 52. Teva Pharmaceutical Recent Development Table 53. Merck & Co. Company Information Table 54. Merck & Co. Business Overview Table 55. Merck & Co. Contact-lens Induced Infection Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Merck & Co. Contact-lens Induced Infection Product Portfolio Table 57. Merck & Co. Recent Development Table 58. Pfizer Company Information Table 59. Pfizer Business Overview Table 60. Pfizer Contact-lens Induced Infection Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Pfizer Contact-lens Induced Infection Product Portfolio Table 62. Pfizer Recent Development Table 63. Alcon Company Information Table 64. Alcon Business Overview Table 65. Alcon Contact-lens Induced Infection Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Alcon Contact-lens Induced Infection Product Portfolio Table 67. Alcon Recent Development Table 68. AbbVie Company Information Table 69. AbbVie Business Overview Table 70. AbbVie Contact-lens Induced Infection Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. AbbVie Contact-lens Induced Infection Product Portfolio Table 72. AbbVie Recent Development Table 73. Shionogi Company Information Table 74. Shionogi Business Overview Table 75. Shionogi Contact-lens Induced Infection Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Shionogi Contact-lens Induced Infection Product Portfolio Table 77. Shionogi Recent Development Table 78. Santen Pharmaceutical Company Information Table 79. Santen Pharmaceutical Business Overview Table 80. Santen Pharmaceutical Contact-lens Induced Infection Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Santen Pharmaceutical Contact-lens Induced Infection Product Portfolio Table 82. Santen Pharmaceutical Recent Development Table 83. Roche Holding Company Information Table 84. Roche Holding Business Overview Table 85. Roche Holding Contact-lens Induced Infection Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Roche Holding Contact-lens Induced Infection Product Portfolio Table 87. Roche Holding Recent Development Table 88. Otsuka Pharmaceutical Company Information Table 89. Otsuka Pharmaceutical Business Overview Table 90. Otsuka Pharmaceutical Contact-lens Induced Infection Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Otsuka Pharmaceutical Contact-lens Induced Infection Product Portfolio Table 92. Otsuka Pharmaceutical Recent Development Table 93. Novartis International Company Information Table 94. Novartis International Business Overview Table 95. Novartis International Contact-lens Induced Infection Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Novartis International Contact-lens Induced Infection Product Portfolio Table 97. Novartis International Recent Development Table 98. Kowa Company Company Information Table 99. Kowa Company Business Overview Table 100. Kowa Company Contact-lens Induced Infection Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Kowa Company Contact-lens Induced Infection Product Portfolio Table 102. Kowa Company Recent Development Table 103. Hikma Pharmaceuticals Company Information Table 104. Hikma Pharmaceuticals Business Overview Table 105. Hikma Pharmaceuticals Contact-lens Induced Infection Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Hikma Pharmaceuticals Contact-lens Induced Infection Product Portfolio Table 107. Hikma Pharmaceuticals Recent Development Table 108. Dr. Reddy’s Laboratories Company Information Table 109. Dr. Reddy’s Laboratories Business Overview Table 110. Dr. Reddy’s Laboratories Contact-lens Induced Infection Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Dr. Reddy’s Laboratories Contact-lens Induced Infection Product Portfolio Table 112. Dr. Reddy’s Laboratories Recent Development Table 113. Bausch + Lomb Company Information Table 114. Bausch + Lomb Business Overview Table 115. Bausch + Lomb Contact-lens Induced Infection Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Bausch + Lomb Contact-lens Induced Infection Product Portfolio Table 117. Bausch + Lomb Recent Development Table 118. AstraZeneca Company Information Table 119. AstraZeneca Business Overview Table 120. AstraZeneca Contact-lens Induced Infection Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. AstraZeneca Contact-lens Induced Infection Product Portfolio Table 122. AstraZeneca Recent Development Table 123. North America Contact-lens Induced Infection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. North America Contact-lens Induced Infection Market Size by Country (2021-2026) & (US$ Million) Table 125. North America Contact-lens Induced Infection Market Share by Country (2021-2026) Table 126. North America Contact-lens Induced Infection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. North America Contact-lens Induced Infection Market Share Forecast by Country (2027-2032) Table 128. Europe Contact-lens Induced Infection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Europe Contact-lens Induced Infection Market Size by Country (2021-2026) & (US$ Million) Table 130. Europe Contact-lens Induced Infection Market Share by Country (2021-2026) Table 131. Europe Contact-lens Induced Infection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Europe Contact-lens Induced Infection Market Share Forecast by Country (2027-2032) Table 133. Asia-Pacific Contact-lens Induced Infection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Asia-Pacific Contact-lens Induced Infection Market Size by Country (2021-2026) & (US$ Million) Table 135. Asia-Pacific Contact-lens Induced Infection Market Share by Country (2021-2026) Table 136. Asia-Pacific Contact-lens Induced Infection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Asia-Pacific Contact-lens Induced Infection Market Share Forecast by Country (2027-2032) Table 138. Latin America Contact-lens Induced Infection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Latin America Contact-lens Induced Infection Market Size by Country (2021-2026) & (US$ Million) Table 140. Latin America Contact-lens Induced Infection Market Share by Country (2021-2026) Table 141. Latin America Contact-lens Induced Infection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Latin America Contact-lens Induced Infection Market Share Forecast by Country (2027-2032) Table 143. Middle East & Africa Contact-lens Induced Infection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Middle East & Africa Contact-lens Induced Infection Market Size by Country (2021-2026) & (US$ Million) Table 145. Middle East & Africa Contact-lens Induced Infection Market Share by Country (2021-2026) Table 146. Middle East & Africa Contact-lens Induced Infection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Middle East & Africa Contact-lens Induced Infection Market Share Forecast by Country (2027-2032) Table 148. Research Programs/Design for This Report Table 149. Authors List of This Report Table 150. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Contact-lens Induced Infection Product Image Figure 3. Global Contact-lens Induced Infection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Contact-lens Induced Infection Market Size (2021-2032) & (US$ Million) Figure 5. Global Contact-lens Induced Infection Market Share by Region: 2025 VS 2032 Figure 6. Global Contact-lens Induced Infection Market Share by Region (2021-2032) Figure 7. North America Contact-lens Induced Infection Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Contact-lens Induced Infection Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Contact-lens Induced Infection Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Contact-lens Induced Infection Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Contact-lens Induced Infection Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Corticosteroids Image Figure 13. Global Corticosteroids Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Anti-inflammatory Drugs Image Figure 15. Global Anti-inflammatory Drugs Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Antibiotics Image Figure 17. Global Antibiotics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. NSAIDs Image Figure 19. Global NSAIDs Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Other Image Figure 21. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 22. Global Contact-lens Induced Infection Market Size Overview by Type (2021-2032) & (US$ Million) Figure 23. Global Contact-lens Induced Infection Market Share by Type 2025 VS 2032 Figure 24. North America Contact-lens Induced Infection Market Size Share by Type (2021-2032) Figure 25. Europe Contact-lens Induced Infection Market Size Share by Type (2021-2032) Figure 26. Asia-Pacific Contact-lens Induced Infection Market Size Share by Type (2021-2032) Figure 27. Latin America Contact-lens Induced Infection Market Size Share by Type (2021-2032) Figure 28. Middle East and Africa Contact-lens Induced Infection Market Size Share by Type (2021-2032) Figure 29. Retail Pharmacy Image Figure 30. Global Retail Pharmacy Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Ophthalmology Clinics Image Figure 32. Global Ophthalmology Clinics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Hospitals Image Figure 34. Global Hospitals Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Other Image Figure 36. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Global Contact-lens Induced Infection Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global Contact-lens Induced Infection Market Share by Application 2025 VS 2032 Figure 39. North America Contact-lens Induced Infection Market Size Share by Application (2021-2032) Figure 40. Europe Contact-lens Induced Infection Market Size Share by Application (2021-2032) Figure 41. Asia-Pacific Contact-lens Induced Infection Market Size Share by Application (2021-2032) Figure 42. Latin America Contact-lens Induced Infection Market Size Share by Application (2021-2032) Figure 43. Middle East and Africa Contact-lens Induced Infection Market Size Share by Application (2021-2032) Figure 44. Global Top 5 and 10 Contact-lens Induced Infection Players Market Share by Revenue in 2025 Figure 45. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 46. North America Contact-lens Induced Infection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 47. North America Contact-lens Induced Infection Market Share by Country: 2021 VS 2025 VS 2032 Figure 48. North America Contact-lens Induced Infection Market Share by Country (2021-2032) Figure 49. Europe Contact-lens Induced Infection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Contact-lens Induced Infection Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Contact-lens Induced Infection Market Share by Country (2021-2032) Figure 52. Asia-Pacific Contact-lens Induced Infection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 53. Asia-Pacific Contact-lens Induced Infection Market Share by Country: 2021 VS 2025 VS 2032 Figure 54. Asia-Pacific Contact-lens Induced Infection Market Share by Country (2021-2032) Figure 55. Latin America Contact-lens Induced Infection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Contact-lens Induced Infection Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Contact-lens Induced Infection Market Share by Country (2021-2032) Figure 58. Middle East & Africa Contact-lens Induced Infection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Middle East & Africa Contact-lens Induced Infection Market Share by Country: 2021 VS 2025 VS 2032 Figure 60. Middle East & Africa Contact-lens Induced Infection Market Share by Country (2021-2032) Figure 61. Years Considered Figure 62. Research Process Figure 63. Key Executives Interviewed

Scope & coverage.

Types
  • Corticosteroids
  • Anti-inflammatory Drugs
  • Antibiotics
  • NSAIDs
  • Other
Applications
  • Retail Pharmacy
  • Ophthalmology Clinics
  • Hospitals
  • Other
Companies covered
  • Teva Pharmaceutical
  • Merck & Co.
  • Pfizer
  • Alcon
  • AbbVie
  • Shionogi
  • Santen Pharmaceutical
  • Roche Holding
  • Otsuka Pharmaceutical
  • Novartis International
  • Kowa Company
  • Hikma Pharmaceuticals
  • Dr. Reddy’s Laboratories
  • Bausch + Lomb
  • AstraZeneca

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Contact-lens Induced Infection Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Contact-lens Induced Infection Market Size by Region (2021-2032)
  5. 1.4.1 Global Contact-lens Induced Infection Market Size by Region (2021-2026)
  6. 1.4.2 Global Contact-lens Induced Infection Market Size by Region (2027-2032)
  7. 1.5 Key Regions Contact-lens Induced Infection Market Size (2021-2032)
  8. 1.5.1 North America Contact-lens Induced Infection Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Contact-lens Induced Infection Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Contact-lens Induced Infection Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Contact-lens Induced Infection Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Contact-lens Induced Infection Market Size Growth Rate (2021-2032)
2 Contact-lens Induced Infection Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Corticosteroids
  3. 2.1.2 Anti-inflammatory Drugs
  4. 2.1.3 Antibiotics
  5. 2.1.4 NSAIDs
  6. 2.1.5 Other
  7. 2.2 Global Contact-lens Induced Infection Market Size by Type
  8. 2.2.1 Global Contact-lens Induced Infection Market Size Overview by Type (2021-2032)
  9. 2.2.2 Global Contact-lens Induced Infection Historic Market Size Review by Type (2021-2026)
  10. 2.2.3 Global Contact-lens Induced Infection Market Size Forecasted by Type (2027-2032)
  11. 2.3 Global Contact-lens Induced Infection Market Size by Regions
  12. 2.3.1 North America Contact-lens Induced Infection Market Size Breakdown by Type (2021-2026)
  13. 2.3.2 Europe Contact-lens Induced Infection Market Size Breakdown by Type (2021-2026)
  14. 2.3.3 Asia-Pacific Contact-lens Induced Infection Market Size Breakdown by Type (2021-2026)
  15. 2.3.4 South America Contact-lens Induced Infection Market Size Breakdown by Type (2021-2026)
  16. 2.3.5 Middle East and Africa Contact-lens Induced Infection Market Size Breakdown by Type (2021-2026)
3 Contact-lens Induced Infection Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Retail Pharmacy
  3. 3.1.2 Ophthalmology Clinics
  4. 3.1.3 Hospitals
  5. 3.1.4 Other
  6. 3.2 Global Contact-lens Induced Infection Market Size by Application
  7. 3.2.1 Global Contact-lens Induced Infection Market Size Overview by Application (2021-2032)
  8. 3.2.2 Global Contact-lens Induced Infection Historic Market Size Review by Application (2021-2026)
  9. 3.2.3 Global Contact-lens Induced Infection Market Size Forecasted by Application (2027-2032)
  10. 3.3 Global Contact-lens Induced Infection Market Size by Regions
  11. 3.3.1 North America Contact-lens Induced Infection Market Size Breakdown by Application (2021-2026)
  12. 3.3.2 Europe Contact-lens Induced Infection Market Size Breakdown by Application (2021-2026)
  13. 3.3.3 Asia-Pacific Contact-lens Induced Infection Market Size Breakdown by Application (2021-2026)
  14. 3.3.4 South America Contact-lens Induced Infection Market Size Breakdown by Application (2021-2026)
  15. 3.3.5 Middle East and Africa Contact-lens Induced Infection Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Contact-lens Induced Infection Industry Trends
  2. 4.2 Contact-lens Induced Infection Industry Drivers
  3. 4.3 Contact-lens Induced Infection Industry Opportunities and Challenges
  4. 4.4 Contact-lens Induced Infection Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Contact-lens Induced Infection Revenue (2021-2026)
  2. 5.2 Global Contact-lens Induced Infection Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Contact-lens Induced Infection Key Company Headquarters & Area Served
  4. 5.4 Global Contact-lens Induced Infection Company, Product Type & Application
  5. 5.5 Global Contact-lens Induced Infection Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Contact-lens Induced Infection Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Contact-lens Induced Infection Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Contact-lens Induced Infection Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Teva Pharmaceutical
  2. 6.1.1 Teva Pharmaceutical Company Information
  3. 6.1.2 Teva Pharmaceutical Business Overview
  4. 6.1.3 Teva Pharmaceutical Contact-lens Induced Infection Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Teva Pharmaceutical Contact-lens Induced Infection Product Portfolio
  6. 6.1.5 Teva Pharmaceutical Recent Developments
  7. 6.2 Merck & Co.
  8. 6.2.1 Merck & Co. Company Information
  9. 6.2.2 Merck & Co. Business Overview
  10. 6.2.3 Merck & Co. Contact-lens Induced Infection Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Merck & Co. Contact-lens Induced Infection Product Portfolio
  12. 6.2.5 Merck & Co. Recent Developments
  13. 6.3 Pfizer
  14. 6.3.1 Pfizer Company Information
  15. 6.3.2 Pfizer Business Overview
  16. 6.3.3 Pfizer Contact-lens Induced Infection Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Pfizer Contact-lens Induced Infection Product Portfolio
  18. 6.3.5 Pfizer Recent Developments
  19. 6.4 Alcon
  20. 6.4.1 Alcon Company Information
  21. 6.4.2 Alcon Business Overview
  22. 6.4.3 Alcon Contact-lens Induced Infection Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Alcon Contact-lens Induced Infection Product Portfolio
  24. 6.4.5 Alcon Recent Developments
  25. 6.5 AbbVie
  26. 6.5.1 AbbVie Company Information
  27. 6.5.2 AbbVie Business Overview
  28. 6.5.3 AbbVie Contact-lens Induced Infection Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 AbbVie Contact-lens Induced Infection Product Portfolio
  30. 6.5.5 AbbVie Recent Developments
  31. 6.6 Shionogi
  32. 6.6.1 Shionogi Company Information
  33. 6.6.2 Shionogi Business Overview
  34. 6.6.3 Shionogi Contact-lens Induced Infection Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Shionogi Contact-lens Induced Infection Product Portfolio
  36. 6.6.5 Shionogi Recent Developments
  37. 6.7 Santen Pharmaceutical
  38. 6.7.1 Santen Pharmaceutical Company Information
  39. 6.7.2 Santen Pharmaceutical Business Overview
  40. 6.7.3 Santen Pharmaceutical Contact-lens Induced Infection Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Santen Pharmaceutical Contact-lens Induced Infection Product Portfolio
  42. 6.7.5 Santen Pharmaceutical Recent Developments
  43. 6.8 Roche Holding
  44. 6.8.1 Roche Holding Company Information
  45. 6.8.2 Roche Holding Business Overview
  46. 6.8.3 Roche Holding Contact-lens Induced Infection Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Roche Holding Contact-lens Induced Infection Product Portfolio
  48. 6.8.5 Roche Holding Recent Developments
  49. 6.9 Otsuka Pharmaceutical
  50. 6.9.1 Otsuka Pharmaceutical Company Information
  51. 6.9.2 Otsuka Pharmaceutical Business Overview
  52. 6.9.3 Otsuka Pharmaceutical Contact-lens Induced Infection Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Otsuka Pharmaceutical Contact-lens Induced Infection Product Portfolio
  54. 6.9.5 Otsuka Pharmaceutical Recent Developments
  55. 6.10 Novartis International
  56. 6.10.1 Novartis International Company Information
  57. 6.10.2 Novartis International Business Overview
  58. 6.10.3 Novartis International Contact-lens Induced Infection Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Novartis International Contact-lens Induced Infection Product Portfolio
  60. 6.10.5 Novartis International Recent Developments
  61. 6.11 Kowa Company
  62. 6.11.1 Kowa Company Company Information
  63. 6.11.2 Kowa Company Business Overview
  64. 6.11.3 Kowa Company Contact-lens Induced Infection Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Kowa Company Contact-lens Induced Infection Product Portfolio
  66. 6.11.5 Kowa Company Recent Developments
  67. 6.12 Hikma Pharmaceuticals
  68. 6.12.1 Hikma Pharmaceuticals Company Information
  69. 6.12.2 Hikma Pharmaceuticals Business Overview
  70. 6.12.3 Hikma Pharmaceuticals Contact-lens Induced Infection Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Hikma Pharmaceuticals Contact-lens Induced Infection Product Portfolio
  72. 6.12.5 Hikma Pharmaceuticals Recent Developments
  73. 6.13 Dr. Reddy’s Laboratories
  74. 6.13.1 Dr. Reddy’s Laboratories Company Information
  75. 6.13.2 Dr. Reddy’s Laboratories Business Overview
  76. 6.13.3 Dr. Reddy’s Laboratories Contact-lens Induced Infection Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Dr. Reddy’s Laboratories Contact-lens Induced Infection Product Portfolio
  78. 6.13.5 Dr. Reddy’s Laboratories Recent Developments
  79. 6.14 Bausch + Lomb
  80. 6.14.1 Bausch + Lomb Company Information
  81. 6.14.2 Bausch + Lomb Business Overview
  82. 6.14.3 Bausch + Lomb Contact-lens Induced Infection Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Bausch + Lomb Contact-lens Induced Infection Product Portfolio
  84. 6.14.5 Bausch + Lomb Recent Developments
  85. 6.15 AstraZeneca
  86. 6.15.1 AstraZeneca Company Information
  87. 6.15.2 AstraZeneca Business Overview
  88. 6.15.3 AstraZeneca Contact-lens Induced Infection Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 AstraZeneca Contact-lens Induced Infection Product Portfolio
  90. 6.15.5 AstraZeneca Recent Developments
7 North America
  1. 7.1 North America Contact-lens Induced Infection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Contact-lens Induced Infection Market Size by Country (2021-2026)
  3. 7.3 North America Contact-lens Induced Infection Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Contact-lens Induced Infection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Contact-lens Induced Infection Market Size by Country (2021-2026)
  3. 8.3 Europe Contact-lens Induced Infection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Contact-lens Induced Infection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Contact-lens Induced Infection Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Contact-lens Induced Infection Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Contact-lens Induced Infection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Contact-lens Induced Infection Market Size by Country (2021-2026)
  3. 10.3 South America Contact-lens Induced Infection Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Contact-lens Induced Infection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Contact-lens Induced Infection Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Contact-lens Induced Infection Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst